This is the accessible text file for GAO report number GAO-04-718 
entitled 'Contract Management: Further Efforts Needed to Sustain VA's 
Progress in Purchasing Medical Products and Services' which was 
released on July 22, 2004.

This text file was formatted by the U.S. Government Accountability 
Office (GAO) to be accessible to users with visual impairments, as part 
of a longer term project to improve GAO products' accessibility. Every 
attempt has been made to maintain the structural and data integrity of 
the original printed product. Accessibility features, such as text 
descriptions of tables, consecutively numbered footnotes placed at the 
end of the file, and the text of agency comment letters, are provided 
but may not exactly duplicate the presentation or format of the printed 
version. The portable document format (PDF) file is an exact electronic 
replica of the printed version. We welcome your feedback. Please E-mail 
your comments regarding the contents or accessibility features of this 
document to Webmaster@gao.gov.

This is a work of the U.S. government and is not subject to copyright 
protection in the United States. It may be reproduced and distributed 
in its entirety without further permission from GAO. Because this work 
may contain copyrighted images or other material, permission from the 
copyright holder may be necessary if you wish to reproduce this 
material separately.

Report to the Committee on Government Reform, House of Representatives:

United States General Accounting Office:

GAO:

June 2004:

Contract Management:

Further Efforts Needed to Sustain VA's Progress in Purchasing Medical 
Products and Services:

GAO-04-718:

GAO Highlights:

Highlights of GAO-04-718, a report to the Committee on Government 
Reform, House of Representatives

Why GAO Did This Study:

The Department of Veterans Affairs (VA) provides healthcare to millions 
of veterans at VA’s medical centers and healthcare facilities across 
the country. To support veterans, VA manages a Federal Supply Schedule 
(FSS) program and a national contract program.  Both use VA’s sizeable 
buying power to provide VA and other federal agencies discounts on 
medical products and services. To cover its costs in running the FSS 
program, VA charges its customers a user fee. 

Although sales through VA’s FSS and national contracts totaled almost 
$7 billion in fiscal year 2003, concerns have been raised about the 
efficiency of these contract programs. GAO was asked to determine 
whether the FSS and national contracts have provided medical products 
at favorable prices and to identify opportunities to improve purchasing 
practices and increase savings. GAO was also asked to determine if VA’s 
user fee is sufficient to cover program cost.

What GAO Found:

The more than 1,200 FSS and 330 national contracts that VA has awarded 
have resulted in more competitive prices and have yielded substantial 
savings. VA has achieved these favorable prices and savings, in part, 
by exercising its audit rights and access to contractor data to pursue 
best prices aggressively for medical supplies and services. For 
example, pre-award audits of vendors’ contract proposals and post-award 
audits of vendors’ contract actions resulted in savings of about $240 
million during fiscal years 1999 to 2003. VA has also taken steps to 
further leverage its buying power on widely used healthcare items—such 
as pharmaceuticals and high-tech medical equipment—through its national 
contracts. According to VA, its national pharmaceutical contracts have 
led to a cost avoidance of $394 million in fiscal year 2003. However, 
VA has not taken the same aggressive approach to negotiate more 
competitive prices for healthcare services, such as radiology. In 
fiscal year 2003, healthcare services totaled about $1.7 billion, yet 
VA facilities only purchased about $66 million through VA FSS 
contracts. Instead, most medical healthcare services are purchased 
through contracts that individual VA medical centers have negotiated, a 
process that may not provide the most favorable prices. 

VA could also realize additional savings through improved medical 
center purchasing practices. Despite increases in medical centers’ FSS 
purchases—which more than doubled between fiscal years 1999 and 
2003—medical centers have not always taken advantage of the best prices 
available through VA’s contracts. For example, in fiscal year 2001, a 
VA Inspector General (IG) report stated that VA medical centers 
frequently purchased healthcare products from local sources, instead of 
from available FSS contracts. Although VA has since implemented 
policies and procedures that generally require its medical centers to 
purchase medical products and services through VA’s contract programs, 
a more recent VA IG report found that medical centers continued to make 
purchases from local suppliers. The VA IG estimated that, with improved 
procurement practices at medical centers, VA could save about $1.4 
billion over 5 years. However, ensuring VA medical centers comply with 
VA’s purchasing policies and procedures will be a challenge for VA, in 
part, because its monitoring of purchases lacks adequate rigor.

The user fee that VA collects on FSS purchases—0.5 percent of sales—is 
expected to approximate the program costs. VA, however, does not have 
complete information on the costs to administer the FSS program. 
Without this cost data, VA is unable to know whether it is charging an 
appropriate user fee.

What GAO Recommends:

GAO recommends that VA use its buying power to obtain more favorable 
prices for healthcare services, and strengthen oversight to ensure its 
medical centers obtain the best available prices. GAO also recommends 
that VA identify the complete cost of the FSS program and reassess its 
user fee to see if it needs to be adjusted. VA concurred with GAO’s 
recommendations. 

www.gao.gov/cgi-bin/getrpt?GAO-04-718.

To view the full product, including the scope and methodology, click on 
the link above. For more information, contact David Cooper at (202) 
512-4841 or cooperd@gao.gov.

[End of Section]

Contents:

Letter:

Results in Brief:

Background:

Many VA Contracts Offer Favorable Prices and Savings, but VA Could 
Further Leverage Its Buying Power When Acquiring Healthcare Services:

Opportunities Exist to Obtain Additional Savings at the 
Medical Centers:

VA Does Not Have Complete Information on the FSS Program Costs:

Conclusions:

Recommendations for Executive Action:

Agency Comments:

Scope and Methodology:

Appendix I: Description of Products and Services Included in FSS 
Schedules:

Appendix II: Comments From the Department of Veterans Affairs:

Tables:

Table 1: Results of VA FSS Audits for Fiscal Years 1999 through 2003:

Table 2: Fiscal Year 2003 Healthcare Services Purchased from Vendors 
and Other Providers:

Table 3: Summary of FSS Purchases by VA Medical Centers in Fiscal Years 
1999 through 2003:

Table 4: FSS Schedule Name and Description of Items:

Figure:

Figure 1: FSS and National Contract Sales, Fiscal Years 1999 through 
2003:

Abbreviations:

BPA: Blanket purchase agreement:

FSS: Federal Supply Schedule:

IG: Inspector General:

VA: Department of Veterans Affairs:

United States General Accounting Office:

Washington, DC 20548:

June 22, 2004:

The Honorable Tom Davis: 
Chairman: 
The Honorable Henry A. Waxman: 
Ranking Minority Member: 
Committee on Government Reform: 
House of Representatives:

In fiscal year 2003, the Department of Veterans Affairs (VA) spent 
over $26 billion to provide healthcare to 4.5 million veterans at VA's 
medical centers and other VA healthcare facilities across the country. 
To provide healthcare services for veterans, VA operates a Federal 
Supply Schedule (FSS) program, which provides VA and other federal 
agencies access to over 1,200 contracts for buying medical 
products[Footnote 1] and services from a wide range of vendors. Vendor 
prices are expected to be at least as good as those offered to the 
vendors' most favored customers.[Footnote 2] To cover the cost of 
operating the FSS program, VA charges its customers a user fee. Once VA 
has awarded an FSS contract for a medical product, it looks for 
opportunities to award a national contract that can provide even better 
prices. In fiscal year 2003, VA sales through the FSS program were 
$6.2 billion, and sales from national contracts were $712 million.

As one of the largest buyers of medical equipment, products, and 
services, VA has the ability to realize significant savings and achieve 
management efficiencies by leveraging its vast purchasing power. At 
your request, we reviewed VA's contract programs. Specifically, you 
asked us to (1) determine whether VA's FSS and national contracts 
provide medical products at favorable prices and achieve savings, 
(2) identify opportunities to improve purchasing practices and increase 
savings at VA medical centers, and (3) determine if the FSS user fee is 
sufficient to cover the program's costs.

To conduct our work, we reviewed VA's policies, procedures, and 
internal controls associated with awarding and administering FSS and 
national contracts. We also reviewed a May 2002 report by VA's 
Procurement Reform Task Force and determined the status of VA's 
implementation of task force recommendations to improve procurement 
practices across VA. We met with officials from procurement and 
financial management activities at VA Headquarters and officials at the 
National Acquisition Center, which is responsible for managing both the 
FSS program and the national contracts program. We conducted our review 
from July 2003 through April 2004 in accordance with generally accepted 
government auditing standards. A more detailed discussion of our scope 
and methodology is at the end of the letter.

Results in Brief:

VA's FSS and national contracts generally provide favorable prices 
and have achieved savings--in part, because VA has built into its 
contracts important clauses that allow it to aggressively pursue best 
prices for medical products and services. For example, through its FSS 
contracts, VA exercises audit rights and access to contractor data, 
which have helped VA negotiate better prices and achieve savings 
totaling about $240 million from fiscal years 1999 to 2003. Consistent 
with a prior GAO recommendation, VA has also emphasized using national 
contracts to standardize and further leverage VA's buying power on 
widely used healthcare items, such as pharmaceuticals, medical 
supplies, and high-tech medical equipment.[Footnote 3] According to VA 
officials, VA plans to expand the use of national contracts to 
negotiate even better prices. However, VA could achieve additional 
savings. For example, to date, VA has rarely used its contracting 
programs to leverage its buying power when acquiring healthcare 
services. In fiscal year 2003, these services totaled about 
$1.7 billion, yet VA only purchased about $66 million through VA FSS 
contracts. Instead, most healthcare services are currently contracted 
for by individual VA medical centers, a process that may not result in 
the centers receiving favorable prices.

VA also has opportunities to improve purchasing practices and increase 
savings at its medical centers. Most notably, VA medical centers have 
not always taken advantage of the best prices available through FSS and 
national contracts. In fiscal year 2001, a VA audit report stated that 
VA medical centers frequently purchased healthcare products from local 
sources instead of from an FSS contract, in part because FSS contracts 
were not used as a primary source of supply. In response to the 
Procurement Reform Task Force's May 2002 recommendations, VA 
implemented purchasing policies and procedures that require its medical 
centers to use VA's contracts, to the extent feasible, to purchase 
medical supplies and services. However, a March 2004 VA audit report 
found that medical centers have continued to make purchases from local 
suppliers, indicating that VA's oversight of medical center purchasing 
may not be sufficient to ensure that centers comply with its purchasing 
policies and procedures. The audit report estimated that VA could save 
about $1.4 billion over 5 years by using FSS and national contracts 
with more favorable prices.

To operate the FSS program, VA is supposed to identify all program 
costs and charge a fee to its customers to recover these costs. 
Currently, VA charges FSS users a fee of 0.5 percent of sales. VA, 
however, does not have complete information on the costs to administer 
the FSS program. While VA maintains FSS data on some program costs, it 
has not identified the amount of the FSS fees associated with each of 
the activities that support the program.

To improve VA procurement practices, we are recommending that VA take 
steps to (1) explore opportunities to use its buying power to obtain 
more favorable prices for healthcare services, (2) strengthen oversight 
to ensure medical centers use FSS and national contracts to get the 
best prices available, and (3) identify the complete cost of the FSS 
program and reassess its user fee to determine if it needs to be 
adjusted. In commenting on a draft of this report, VA agreed with GAO's 
conclusions and concurred with its recommendations. VA's comments are 
included in appendix II.

Background:

VA operates one of the world's largest healthcare systems.[Footnote 4] 
In fiscal year 2003, VA spent about $26 billion to provide healthcare 
to 4.5 million veterans. More than 1,300 VA healthcare facilities, 
which include 160 medical centers, provide a range of medical, 
surgical, outpatient, rehabilitative, and long-term care products and 
services. Between fiscal years 2001 and 2003, VA experienced over a 15-
percent growth in the number of patients treated.

The General Services Administration established the FSS program in 1949 
to facilitate federal agencies' acquisition of products and services 
from commercial suppliers through schedule contracts. In 1960, the 
General Services Administration delegated authority to VA to manage and 
award FSS contracts for all medical products and services needed 
throughout the federal healthcare system. VA currently operates eight 
schedules that cover a wide range of medical products and services. 
(See app. I for a complete list of the schedules.) In addition, VA 
currently has two new schedules under consideration. The first, 
laboratory tests, will be an expansion of VA's "clinical analyzers" 
schedule and will be used for off-site tests such as cytology, 
pathology, and endocrinology. The second schedule, "home infusion," 
will be used for intravenous services at nonmedical facility sites, 
such as patients' homes. VA projects that these two schedules will be 
available by the end of fiscal year 2004.

Currently, VA has over 1,200 FSS contracts in place for the eight 
schedules. These FSS contracts are available for use by all government 
agencies, including VA, the Department of Defense, Bureau of Prisons, 
Indian Health Services, Public Health Services, and some state veterans 
homes. All schedules are multiple award contracts with performance 
periods up to 5 years, under which many vendors that meet all 
competition requirements have contracts to sell products and services 
to the federal government. For example, under the pharmaceutical 
schedule, all manufacturers of aspirin can have a contract to sell 
their products to government agencies.

Since 1993, VA has been competitively awarding national contracts 
with vendors for a larger discount based on volume purchasing. As of 
April 2004, VA had about 330 national contracts. National contracts are 
best suited for products that are widely used and where competition is 
practical, such as pharmaceuticals and basic surgical supplies, and 
where clinicians are likely to agree to standardized product use across 
all VA medical centers. A national contract may also include 
requirements of other federal agencies such as the Department of 
Defense.

Since 1999, VA's FSS and national contract sales have steadily grown 
(see fig. 1).

Figure 1: FSS and National Contract Sales, Fiscal Years 1999 through 
2003:

[See PDF for image]

[End of figure]

VA medical centers account for more than half of all VA FSS sales. In 
fiscal year 2003, for example, VA medical center purchases represented 
$3.9 billion, or over 63 percent, of the $6.2 billion in total sales 
from VA's schedule contracts. While purchases from national contracts 
were much less than those from the schedules--totaling approximately 
$712 million in fiscal year 2003--VA medical centers accounted for 
about $591 million, or 83 percent, of the purchases from these 
contracts.

VA's National Acquisition Center is responsible for awarding and 
administering FSS and national contracts. The National Acquisition 
Center negotiates contracts, seeking to leverage VA's overall 
government buying power by achieving pricing and terms equal to or 
better than those a vendor offers its most favored customers. Vendors 
submit offers to the National Acquisition Center, and contracting 
officers perform price analyses to arrive at a fair and reasonable 
price.[Footnote 5] Once the contracts are in place, it is then up to 
the purchasing offices at the VA medical centers to buy products and 
services from the schedules.

In fiscal year 2001, the VA Inspector General (IG) issued a report that 
expressed significant concerns about the effectiveness of VA's 
acquisition system.[Footnote 6] As a result, the Secretary of Veterans 
Affairs established, in June 2001, a Procurement Reform Task Force to 
review VA's healthcare procurement system. In its May 2002 report, the 
task force set five major goals that it believed would lead to 
improvements in VA's acquisition system: (1) leverage purchasing power, 
(2) standardize commodities in VA, (3) obtain and improve comprehensive 
procurement information for better decision making, (4) improve the 
effectiveness of the procurement organization, and (5) ensure that it 
maintained a talented and sufficient procurement workforce. The task 
force made recommendations to help VA achieve these goals.

Many VA Contracts Offer Favorable Prices and Savings, but VA Could 
Further Leverage Its Buying Power When Acquiring Healthcare Services:

The FSS and national contracts that VA has awarded have resulted in 
more favorable prices and yielded substantial savings. To strengthen 
its bargaining position during FSS contract negotiations, VA has relied 
on pre-award audits of vendors' contract proposals and post-award 
audits of vendors' contract actions. VA has further leveraged its 
buying power to achieve discounts and savings through its national 
contracts--an area that the VA Procurement Reform Task Force recognized 
offered significant potential for additional cost savings and other 
procurement efficiencies. However, VA could achieve additional savings 
through FSS and national contracts for healthcare services.

Audits Have Helped VA Obtain Most Favored Customer Prices and Savings:

To help ensure VA obtains most favored customer prices on FSS contracts 
for medical products and services, VA's Office of Inspector General 
entered into a memorandum of understanding with VA's Office of 
Acquisition and Materiel Management to conduct pre-award and post-award 
audits of FSS contracts. These audits provide VA's contracting officers 
with detailed information about vendors' commercial sales and marketing 
practices. With this information, VA is able to strengthen the 
government's bargaining position during negotiations and achieve 
savings through cost avoidance and recoveries.

VA policy requires that pre-award audits be conducted before awarding 
pharmaceutical contracts of $25 million or more, and other contracts of 
$15 million or more.[Footnote 7] By performing a pre-award audit on a 
vendor's proposal, VA can determine whether the pricing information is 
current, accurate, and complete. Pre-award audits help VA avoid 
unnecessary costs by obtaining the most favored customer price during 
negotiations. Post-award audits also help VA protect against 
overcharging by vendors. They often result in recovery of money from 
vendors who overcharged VA. Most post-award audits are prompted by 
vendors' voluntary disclosures that prices charged to the government 
were too high.

The financial benefits attributed to these audit efforts have been 
significant. During fiscal years 1999 to 2003, VA audits identified 
$151 million in cost avoidances from pre-award audits and $90 million 
in recoveries from post-award audits (see table 1).

Table 1: Results of VA FSS Audits for Fiscal Years 1999 through 2003:

Dollars in millions.

Fiscal year: 1999; 
Cost avoidance: $32.7; 
Recoveries: $10.2; 
Total: $42.9.

Fiscal year: 2000; 
Cost avoidance: $20.2; 
Recoveries: $5.9; 
Total: 26.1.

Fiscal year: 2001; 
Cost avoidance: $17.1; 
Recoveries: $24.4; 
Total: 41.5.

Fiscal year: 2002; 
Cost avoidance: $22.6; 
Recoveries: $25.0; 
Total: 47.6.

Fiscal year: 2003; 
Cost avoidance: $58.2; 
Recoveries: $24.3; 
Total: 82.5.

Total; 
Cost avoidance: $150.8; 
Recoveries: $89.8; 
Total: $240.6.

Source: VA data.

[End of table]

National Contracts Have Resulted in Additional Savings:

VA has also taken steps when possible to consolidate its requirements 
for medical supplies and equipment and pharmaceutical products it 
purchases by using national contracts. Through these contracts, VA has 
been able to further leverage its buying power and obtain even better 
prices than are available on FSS contracts.[Footnote 8] VA uses three 
methods to consolidate requirements into national contracts.

First, VA consolidates contracts through "standardization"--that is, it 
agrees on particular items that VA facilities purchase and then 
contracts with manufacturers of these items for discounts based on a 
larger volume.[Footnote 9] By leveraging its large purchasing power, VA 
can achieve significant cost savings and other procurement 
efficiencies. VA's standardization efforts cover a variety of medical 
products, such as medical and surgical supplies and prosthetic 
equipment, but most of VA's standardization has involved buying 
pharmaceutical products at large discounts. Since VA issued a policy in 
June 1999 requiring medical facilities to use standardized products, VA 
increased its use of national contracts. According to VA officials, 
VA's pharmaceutical standardization program led to savings of 
$394 million for 84 categories of drugs in fiscal year 2003.[Footnote 
10] VA continues to look for opportunities for more national contracts. 
For example, in fiscal year 2003, the National Acquisition Center 
awarded 73 contracts for standardized medical products valued at 
$34 million and 12 additional national pharmaceuticals contracts valued 
at $227 million.

Second, VA consolidates its purchases of high-tech medical equipment to 
achieve additional savings. For example, the National Acquisition 
Center has negotiated national contracts with major equipment 
manufacturers for ordering X-ray, magnetic resonance imaging, 
diagnostic ultrasound, and other high-tech medical equipment for VA 
medical centers and other federal customers to obtain discount prices. 
Besides achieving savings through volume purchasing, consolidating 
purchases expedites ordering, reduces costs of administering contracts 
and placing orders, and provides needed technical assistance to users 
in designing a system and resolving any equipment issues. As a result, 
VA officials identified savings of $9 million in fiscal year 2003.

VA's prime vendor distribution contracts---the third contract 
consolidation method VA uses--have also helped VA to achieve savings. 
These contracts provide customers significant flexibility and choice. 
Using these contracts, VA medical centers can place orders through the 
prime vendor,[Footnote 11] which arranges for timely deliveries from 
manufacturers. VA has two prime vendor distribution contracts--one for 
pharmaceuticals and one for medical and surgical products.

* VA's prime vendor distribution contract for pharmaceuticals--which 
has been in effect since 1991--accounts for the distribution of nearly 
all pharmaceuticals used at VA medical centers. The contract provides 
that the prime vendor reimburse VA about 3-percent of pharmaceutical 
sales to medical centers.[Footnote 12] Because this contract 
represented over $3.4 billion in sales in fiscal year 2003, VA 
estimates it saved about $100 million.

* VA's medical and surgical prime vendor distribution contract has been 
in effect since 2002. Total VA sales through the medical and surgical 
prime vendor contract were $48.7 million in fiscal year 2003. According 
to VA officials, this resulted in savings of $2 million. Currently, 
only about one third of VA's medical centers opt to purchase products 
through the prime vendor. To achieve even greater savings and 
efficiencies, VA has made a policy that would require its medical 
centers to purchase all medical and surgical products from a prime 
vendor. According to VA officials, VA's policy should be in full effect 
in fiscal year 2005.

VA Has Potential for Additional Savings When Contracting for 
Healthcare Services:

While the National Acquisition Center has actively looked for ways to 
reduce the cost of pharmaceuticals and medical supplies and equipment, 
it has not taken the same aggressive approach to negotiate more 
favorable prices for healthcare services.[Footnote 13] In fiscal year 
2003, VA medical centers purchased $1.65 billion in healthcare services 
(see table 2). Only $66 million of these services were purchased from 
FSS contracts. In most cases, the healthcare services that the medical 
centers purchased were for procedures or medical tests that could not 
be provided at a VA medical center. For example, one VA medical center 
we visited contracted out radiation therapy services to a local 
hospital because the center did not have the equipment or staff to 
provide such services. In other instances, healthcare services cover 
additional fee-based doctor, nursing, and dental services provided 
inside and outside the VA medical centers.

Table 2: Fiscal Year 2003 Healthcare Services Purchased from Vendors 
and Other Providers:

Description: Medical care contracts and agreements; 
Expenditures: $665,502,189; 
Percent: 40.25%. 

Description: Off-station fee basis-medical and nursing services[A]; 
Expenditures: $385,884,936; 
Percent: 23.34%. 

Description: Scarce medical specialist contracts; 
Expenditures: $228,178,372; 
Percent: 13.80%. 

Description: Contract hospital and outpatient treatment; 
Expenditures: $187,735,882; 
Percent: 11.36%. 

Description: Emergency treatment of veteran; 
Expenditures: $66,759,769; 
Percent: 4.04%. 

Description: Other contract hospitalization; 
Expenditures: $58,591,270; 
Percent: 3.54%. 

Description: On-station fee basis-medical and nursing services[B]; 
Expenditures: $45,677,016; 
Percent: 2.76%. 

Description: Off-station fee basis-dental services[A]; 
Expenditures: $12,318,546; 
Percent: 0.75%. 

Description: Consultants; 
Expenditures: $1,855,481; 
Percent: 0.11%. 

Description: On-station fee basis-dental services[B]; 
Expenditures: $637,007; 
Percent: 0.04%. 

Description: Counseling; 
Expenditures: $187,727; 
Percent: 0.01%. 

Total; 
Expenditures: $1,653,328,195; 
Percent: 100.00%. 

Source: VA data.

[A] Service provided at a non-VA medical facility.

[B] Service provided at a VA medical facility.

[End of table]

Nearly all of VA's existing healthcare services contracts are awarded 
and administered by VA's medical centers. Typically, these contracts 
are with local healthcare providers. As a result, there is generally no 
coordination with the National Acquisition Center as to the type of 
contract arrangements being negotiated, and no assurance that contracts 
represent the best available prices. VA officials acknowledged that the 
area of healthcare services has not been reviewed to determine the 
potential for requirement consolidation and leveraging its buying 
power. These officials, however, also explained that VA needs a 
database that captures the specific types of healthcare services used 
by its medical centers to determine which healthcare services could be 
consolidated to achieve additional savings. We believe the National 
Acquisition Center is in the best position to negotiate contracts that 
would help ensure more favorable prices for healthcare services--as it 
does for pharmaceuticals, medical supplies, and equipment--and could 
take steps to do this.

Opportunities Exist to Obtain Additional Savings at the Medical 
Centers:

Over the past several years, VA medical center purchases from contracts 
with more favorable prices have increased significantly, and VA has 
achieved substantial savings. However, these savings could have been 
even greater, as medical centers have not used these contracts as much 
as they could have. Although VA has taken several actions to address 
this weakness--including implementing new policies that establish 
purchasing requirements and developing systems to capture data needed 
to make informed acquisition decisions--it has yet to provide 
sufficient oversight to ensure its new policies are adhered to.

Between fiscal years 1999 and 2003, total medical-center FSS purchases 
more than doubled (see table 3). The most frequently used schedule was 
pharmaceuticals.

Table 3: Summary of FSS Purchases by VA Medical Centers in Fiscal Years 
1999 through 2003:

Dollars in millions.

Pharmaceuticals; 
Fiscal year: 1999: $1,239; 
Fiscal year: 2000: $1,571; 
Fiscal year: 2001: $1,957; 
Fiscal year: 2002: $2,477; 
Fiscal year: 2003: $3,237.

Medical equipment and supplies; 
Fiscal year: 1999: $231; 
Fiscal year: 2000: $278; 
Fiscal year: 2001: $297; 
Fiscal year: 2002: $302; 
Fiscal year: 2003: $365.

In-vitro diagnosis and test kits; 
Fiscal year: 1999: $54; 
Fiscal year: 2000: $47; 
Fiscal year: 2001: $59; 
Fiscal year: 2002: $50; 
Fiscal year: 2003: $46.

Lab tests: blood/blood products; 
Fiscal year: 1999: $52; 
Fiscal year: 2000: $69; 
Fiscal year: 2001: $63; 
Fiscal year: 2002: $75; 
Fiscal year: 2003: $86.

Patient mobility devices; 
Fiscal year: 1999: $29; 
Fiscal year: 2000: $28; 
Fiscal year: 2001: $38; 
Fiscal year: 2002: $46; 
Fiscal year: 2003: $50.

X-ray equipment and supplies; 
Fiscal year: 1999: $20; 
Fiscal year: 2000: $18; 
Fiscal year: 2001: $18; 
Fiscal year: 2002: $16; 
Fiscal year: 2003: $16.

Dental supplies; 
Fiscal year: 1999: $7; 
Fiscal year: 2000: $7; 
Fiscal year: 2001: $7; 
Fiscal year: 2002: $8; 
Fiscal year: 2003: $13.

Healthcare services; 
Fiscal year: 1999: N/A; 
Fiscal year: 2000: N/A; 
Fiscal year: 2001: N/A; 
Fiscal year: 2002: $15; 
Fiscal year: 2003: $66.

Total; 
Fiscal year: 1999: $1,632; 
Fiscal year: 2000: $ 2,018; 
Fiscal year: 2001: $2,439; 
Fiscal year: 2002: $2,989; 
Fiscal year: 2003: $3,879. 

Source: VA Data.

[End of table]

Although medical centers' FSS purchases showed an increase between 
fiscal year 1999 and 2001, the VA IG reported in May 2001 that medical 
centers were often not using the VA contracts to purchase medical 
products because medical centers were not required to buy from FSS and 
national contracts. In response, the Procurement Reform Task Force 
recommended that VA establish a contract hierarchy to guide its 
purchasing practices. In November 2002, VA implemented a new 
policy[Footnote 14] requiring VA medical centers to purchase medical 
products first from a national contract, second from a blanket purchase 
agreement (BPA),[Footnote 15] and third from an FSS contract. Only when 
items are not available from these sources should VA medical centers 
enter into local agreements or purchase items directly from local 
vendors--the least desirable option.

Despite these efforts, the VA IG again reported in March 2004 that 
medical center purchases were not made from the best sources.[Footnote 
16] For example, the VA IG analyzed a sample of purchases made in 
fiscal year 2002 valued at $23.4 million. Although all of the products 
were available through VA contracts, the medical centers purchased only 
$14.2 million, or about 60 percent, of the products off the national 
contracts. The remaining $9.2 million, or about 40 percent, was spent 
on generally higher priced locally purchased products. The VA IG 
estimated that over five years (the typical life of national contracts) 
VA could save about $1.4 billion if medical centers purchased medical 
products from FSS and national contracts.

There are two primary reasons why VA medical centers have not purchased 
medical products from the best sources. First, as pointed out by the VA 
task force, VA does not have a readily accessible database that medical 
center personnel could use to determine the availability of medical 
products. VA is developing a web-based searchable database to provide 
catalog information from vendors holding FSS and national contracts. 
The new system, which was partially implemented in July 2003, is being 
designed to allow medical center personnel to search for medical 
surgical products available under FSS contracts and some national 
contracts. According to VA officials, the new system is expected to 
provide access to national contracts by October 2004. Second, according 
to the VA IG, VA has yet to provide adequate oversight to ensure that 
its recently implemented policy to use the contract hierarchy is being 
followed. For example, although two purchasing activities within VA had 
established procedures to monitor compliance with the new policy, the 
procedures only covered compliance with the use of national contracts 
and BPAs and did not cover FSS contracts. Consequently, VA cannot fully 
determine whether medical centers comply with the new contract 
hierarchy.

VA Does Not Have Complete Information on the FSS Program Costs:

To operate the FSS program, VA is supposed to identify all program 
costs and charge a fee to its customers based on these costs. 
Currently, VA charges FSS users a fee of 0.5 percent of sales to cover 
the cost of operating the schedules program.[Footnote 17] VA maintains 
data on some FSS program costs, such as employee salaries and benefits. 
However, VA has not identified the costs associated with other 
activities, such as audit and legal services. Without knowing the full 
cost of administering the program, VA has no assurance that the user 
fee accurately covers program costs.

Conclusions:

VA's aggressive efforts to ensure most favorable pricing in awarding 
FSS and national contacts for medical products and services have saved 
taxpayers hundreds of millions of dollars. Despite this accomplishment, 
VA could achieve significantly more savings--through leveraging its 
purchasing power to negotiate FSS and national contracts for healthcare 
services used at VA's 160 medical centers and through improved 
oversight of medical center purchases. Without such actions, VA risks 
losing opportunities to realize additional savings. At the same time, 
the costs of operating VA's contracting programs need to be better 
understood to ensure that the user fees VA collects from its customers 
are not excessive.

Recommendations for Executive Action:

We are making three recommendations aimed at helping VA achieve maximum 
savings through its contract programs. Specifically, we recommend that 
the Secretary of the Department of Veterans Affairs:

* explore opportunities to use its buying power to obtain more 
favorable prices for healthcare services,

* strengthen oversight to ensure medical centers use FSS and national 
contracts to get the best prices available, and:

* identify the complete cost of the FSS program and reassess its user 
fee to determine if it needs to be adjusted.

Agency Comments:

In commenting on a draft of this report, the Secretary of Veterans 
Affairs agreed with GAO's conclusions and concurred with its 
recommendations. VA's written comments are included in appendix II.

Scope and Methodology:

To identify the steps taken by the VA to ensure that schedule contracts 
provide medical products at favorable prices, we reviewed VA's 
policies, procedures, and internal controls associated with awarding 
and administering FSS contracts, as well as for national contracts that 
are structured to achieve even better prices for VA's customers. We 
discussed implementation of VA policies, procedures and internal 
controls with agency officials at VA's National Acquisition Center in 
Hines, Illinois; VA Headquarters in Washington, D.C; and the VA's 
Office of Inspector General in Washington, D.C. We also visited six VA 
medical centers to help determine how VA procurement practices were 
being implemented. We collected data on FSS and national contracts 
purchases from the National Acquisition Center and the Financial 
Services Center, Austin, Texas. Further, we reviewed and analyzed VA's 
cost avoidance estimates related to the purchase of pharmaceuticals 
from national contracts.

To identify opportunities to improve purchasing practices and increase 
savings, we met with VA medical center procurement officials. We 
reviewed the VA's Procurement Reform Task Force (May 2002) report that 
recommended ways to better leverage VA's purchasing power and 
determined the status of VA's implementation of task force 
recommendations to improve procurement practices across VA. 
Additionally, we reviewed VA IG reports and analyzed VA data on medical 
center procurement practices.

To determine how much the VA spends annually administering the 
schedules program and the extent user fees cover program costs, we 
interviewed and obtained information from officials in the program and 
financial officers at VA headquarters and its National Acquisition 
Center. We asked VA officials to identify the costs incurred to operate 
the schedules program. Further, we reviewed the legislative authority 
that allows VA to use excess fees to cover other program costs. We 
discussed this information with the VA program officials and VA General 
Counsel staff located in Washington, D.C.

As agreed, unless you publicly announce its contents earlier, we plan 
no further distribution of this report until 30 days from its issue 
date. At that time, we will send copies of this report to the Honorable 
Anthony J. Principi, Secretary of Veterans Affairs; appropriate 
congressional committees; and other interested parties. We will also 
provide copies to others on request. In addition, the report will be 
available at no charge on the GAO Web site at http://www.gao.gov.

If you or your staff has questions concerning this report, please 
contact me at (202) 512-4841 or by e-mail at cooperd@gao.gov, or James 
Fuquay at (937) 258-7963. Key contributors to this report were William 
Bricking, Myra Watts Butler, Jean Lee, Fred Naas, Sylvia Schatz, and 
Karen Sloan.

Signed by:

David E. Cooper: 
Director: 
Acquisition and Sourcing Management:

[End of section]

Appendix I: Description of Products and Services Included in FSS 
Schedules:

Table 4: FSS Schedule Name and Description of Items:

Name: Medical/surgical equipment and supplies; 
Description: 
Repair service for home dialysis equipment; 
Home oxygen--contractual agreements; 
Other medical supply; 
Home oxygen--supplies; 
Oxygen equipment & supplies; 
Prosthetic supplies; 
Home dialysis equipment & supply; 
Medical supplies; 
Medical, dental, and scientific equipment; 
Medical, dental and scientific equipment--non-capitalized.

Name: Dental equipment and supplies; 
Description: 
Other medical and dental supply; 
Medical, dental, and scientific equipment; 
Medical, dental and scientific equipment--non-capitalized.

Name: Patient mobility devices; 
Description: 
Equipment rentals; 
Prosthetic repair services and supplies.

Name: X-ray equipment and supplies; 
Description: 
Medical supplies; 
Medical, dental, and scientific equipment; 
Medical, dental and scientific equipment--non-capitalized.

Name: In-vitro diagnostics, reagents and test kits; 
Description: 
Blood and blood products.

Name: Healthcare services; 
Description: 
Medical care contracts and agreements; 
Off-station fee basis medical & nursing services[A]; 
On- station fee basis medical & nursing services[B]; 
Emergency treatment of veteran; 
Off-station fee basis dental services[A]; 
On-station fee basis dental services[B]; 
Other contract hospitalization; 
Consultants and counseling; 
Scarce medical specialist contracts; 
Contract hospital and outpatient treatment.

Name: Pharmaceuticals; 
Description: 
Drugs, medicines and chemical supplies; 
Prescriptions; 
Medicines, drugs, and chemicals.

Name: Laboratory tests, clinical analyzers; 
Description: 
Blood and blood products. 

Source: VA Data.

[A] Service provided at a non-VA medical facility.

[End of section]

[B] Service provided at a VA medical facility.

[End of table]

[End of section]

Appendix II: Comments From the Department of Veterans Affairs:

CONTRACT MANAGEMENT: Further Efforts Needed to Sustain VA's Progress in 
Purchasing Medical Products and Services (GAO-04-718) and agrees with 
your conclusions and concurs with your recommendations.

VA is rightfully proud that its rigorous procurement practices have 
resulted in significant cost savings-dollars that transfer to the care 
of our Nation's veterans. As your draft report illustrates, VA's use of 
pre-and post-award audits have underpinned VA's success in achieving 
these savings.

The enclosure discusses VA's concurrences with the General Accounting 
Office's recommendations. Thank you for the opportunity to comment on 
your draft report.

Sincerely yours,

Signed by:

Anthony J. Principi:

Enclosure:

Department of Veterans Affairs (VA) Comments to:

General Accounting Office (GAO) Draft Report, CONTRACT MANAGEMENT. 
Further Efforts Needed to Sustain VA's Progress in Purchasing Medical 
Products and Services (GAO-04-718):

GAO recommends that the Secretary of the Department of Veterans 
Affairs:

* Explore opportunities to use its buying power to obtain more favorable 
prices for healthcare services,

Concur - VA agrees that some healthcare services, for example 
radiology, could be pursued on a larger scale. The Veterans Health 
Administration (VHA) will explore opportunities to leverage its buying 
power to realize more favorable prices for health care services.

* Strengthen oversight to ensure medical centers use of FSS and national 
contracts to get the best prices available, and:

Concur - In the past year, VHA has taken significant steps to ensure 
medical centers use the Federal Supply Schedule (FSS) and national 
contracts when appropriate. VHA's Office of Clinical Logistics (CLO) 
leads the effort in establishing effective cost-savings procurement 
processes in all areas of medical purchasing. The CLO will continue to 
work closely with VA's Office of Acquisition and Materiel Management 
and the National Acquisition Center (NAC) to achieve the goal of 
obtaining best pricing and value in purchases. Improved oversight and 
accurate data will both be required to achieve best pricing and value 
in purchases.

* Identify the complete cost of the FSS program and reassess its user 
fee to determine if it needs to be adjusted.

Concur - The Office of Acquisition and Materiel Management's Fiscal 
Service will work with the NAC to develop a mechanism that will 
identify the actual costs (direct and indirect) associated with the FSS 
Program. Once this mechanism is approved and implemented, the Office of 
Management will monitor it. Currently, VA charges the lowest fee in the 
Federal government. Annual assessments will be done, and 
recommendations for any changes in the fee will be made to VA's Supply 
Fund Board for approval.

[End of section]

FOOTNOTES

[1] Medical products include medical and surgical supplies as well as 
equipment and pharmaceuticals.

[2] Most favored customer pricing refers to the vendor's best price 
based on the evaluation of discounts, terms, conditions, and 
concessions that are offered to commercial customers for similar 
purchases. The pursuit of most favored customer pricing is consistent 
with the objective of negotiating a fair and reasonable price.

[3] U.S. General Accounting Office, DOD and VA Pharmacy: Progress and 
Remaining Challenges in Jointly Buying and Mailing Out Drugs, 
GAO-01-588 (Washington, D.C.: May 25, 2001).

[4] U.S. General Accounting Office, VA and Defense Health Care: 
Potential Exists for Savings through Joint Purchasing of Medical and 
Surgical Supplies, GAO-02-872T (Washington, D.C.: June 26, 2002).

[5] During negotiations, vendors are required to disclose the prices 
and concessions they offer their most favored customers. The FSS 
multiple award schedules include a Price Reduction Clause that helps to 
ensure that prices remain comparable to the prices granted to the 
vendors' most favored customers throughout the life of the contract. 

[6] Department of Veterans Affairs, Office of Inspector General, 
Evaluation of VA's Purchasing Practices, Report Number 01-01855-75 
(Washington, D.C.: May 15, 2001).

[7] Pre-award audits are generally done at the request of the 
contracting officer.

[8] Most of the solicitations for these contracts are competitive, best 
value procurements. National contracts' performance periods are 
normally for one year with up to four option years.

[9] In standardizing products, VA analyzes its procurement history and 
identifies like items, such as gauze bandages, for which it could 
potentially standardize and negotiate national contracts directly with 
vendors for a larger discount based on volume purchasing. After like 
items are identified, a team of clinicians--including doctors, 
technicians, and nurses--assesses the products for quality and agrees 
on a specific item or items that are acceptable for use by all VA 
hospitals. Acquisition officials then negotiate national contracts with 
the vendors of the chosen products to obtain lower prices.

[10] To determine cost avoidance, VA compared the actual purchase cost 
of the drug types and the theoretical cost had the contracts not been 
awarded. For example, VA determined that a contract for Amiodarone 
(heart medication) awarded in June 2000 resulted in fiscal year 2003 
cost avoidance of $4.7 million, or 58 percent of the actual cost, 
because the cost of the drug in fiscal year 2003 was $3.4 million, and 
the theoretical cost was $8.2 million. VA estimated the theoretical 
cost by multiplying the weighted average price per unit that existed 
during the 3-month period before the contract took effect, by the 
quantity purchased in the current fiscal year. However, VA officials 
noted that its estimates of cost avoidance do not consider factors such 
as inflation and price changes that occurred since some of the older 
contracts were awarded. VA is currently working with DOD to develop a 
more accurate methodology for estimating pharmaceutical cost avoidance.

[11] Prime vendors are contractors that buy inventory from a variety of 
suppliers, store it in commercial warehouses, and ship it to customers 
when ordered.

[12] Under this program, VA pays the prime vendor once the 
pharmaceuticals have been shipped to VA medical centers. The prime 
vendor then generally has up to 15 days to pay manufacturers, giving 
substantial "use of money" benefits to the prime vendor. As a result, 
there is a "negative fee." The current contract, which took effect on 
April 1, 2004, is valued at $2.9 billion per year and includes a 
reimbursement rate of about 5 percent. 

[13] Healthcare services were not included on the FSS until 2001.

[14] The Deputy Assistant Secretary for Acquisition and Materiel 
Management approved a class deviation from VA Acquisition Regulation 
that changed the contracting hierarchy. Class deviation from VAAR 
808.001, Priorities for Use of Government Supply Sources, Nov. 20, 2002

[15] These BPAs are simplified methods of filling anticipated 
repetitive needs for supplies or services currently available on an FSS 
contract. This method allows the government the opportunity to 
negotiate better unit pricing based on anticipated sales volume or 
market share and to provide more timely procurement of products and 
services needed on a recurring basis. For example, the National 
Acquisition Center has negotiated a national BPA for several types of 
anti-embolism stockings. 

[16] Department of Veterans Affairs, Office of Inspector General, Audit 
of VA Medical Center Procurement of Medical, Prosthetic and 
Miscellaneous Operating Supplies, Report Number 02-01481-118 
(Washington, D.C.: Mar. 31, 2004). 

[17] Department of Veterans Affairs has collected this fee since 1996. 
It collected $66.1 million in user fees between fiscal years 2001 and 
2003.

GAO's Mission:

The Government Accountability Office, the investigative arm of 
Congress, exists to support Congress in meeting its constitutional 
responsibilities and to help improve the performance and accountability 
of the federal government for the American people. GAO examines the use 
of public funds; evaluates federal programs and policies; and provides 
analyses, recommendations, and other assistance to help Congress make 
informed oversight, policy, and funding decisions. GAO's commitment to 
good government is reflected in its core values of accountability, 
integrity, and reliability.

Obtaining Copies of GAO Reports and Testimony:

The fastest and easiest way to obtain copies of GAO documents at no 
cost is through the Internet. GAO's Web site ( www.gao.gov ) contains 
abstracts and full-text files of current reports and testimony and an 
expanding archive of older products. The Web site features a search 
engine to help you locate documents using key words and phrases. You 
can print these documents in their entirety, including charts and other 
graphics.

Each day, GAO issues a list of newly released reports, testimony, and 
correspondence. GAO posts this list, known as "Today's Reports," on its 
Web site daily. The list contains links to the full-text document 
files. To have GAO e-mail this list to you every afternoon, go to 
www.gao.gov and select "Subscribe to e-mail alerts" under the "Order 
GAO Products" heading.

Order by Mail or Phone:

The first copy of each printed report is free. Additional copies are $2 
each. A check or money order should be made out to the Superintendent 
of Documents. GAO also accepts VISA and Mastercard. Orders for 100 or 
more copies mailed to a single address are discounted 25 percent. 
Orders should be sent to:

U.S. Government Accountability Office
441 G Street NW, 
Room LM
Washington, D.C. 20548:

To order by Phone:

Voice: (202) 512-6000:

TDD: (202) 512-2537:

Fax: (202) 512-6061:

To Report Fraud, Waste, and Abuse in Federal Programs:

Contact:

Web site: www.gao.gov/fraudnet/fraudnet.htm

E-mail: fraudnet@gao.gov

Automated answering system: (800) 424-5454 or (202) 512-7470:

Public Affairs:

Jeff Nelligan, managing director,
NelliganJ@gao.gov
(202) 512-4800

U.S. Government Accountability Office,
441 G Street NW, Room 7149
Washington, D.C. 20548: